1182 related articles for article (PubMed ID: 32849616)
1. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
Front Immunol; 2020; 11():1731. PubMed ID: 32849616
[TBL] [Abstract][Full Text] [Related]
2. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies.
Nasir I; McGuinness C; Poh AR; Ernst M; Darcy PK; Britt KL
Trends Immunol; 2023 Dec; 44(12):971-985. PubMed ID: 37995659
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing.
Wang J; Zhu N; Su X; Gao Y; Yang R
Front Immunol; 2023; 14():1264774. PubMed ID: 38347955
[TBL] [Abstract][Full Text] [Related]
5. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
[TBL] [Abstract][Full Text] [Related]
6. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
7. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
Guo S; Chen X; Guo C; Wang W
Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
[TBL] [Abstract][Full Text] [Related]
8. Macrophage targeting in cancer.
Lopez-Yrigoyen M; Cassetta L; Pollard JW
Ann N Y Acad Sci; 2021 Sep; 1499(1):18-41. PubMed ID: 32445205
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
10. Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression.
Wang R; Liu Y; Liu L; Chen M; Wang X; Yang J; Gong Y; Ding BS; Wei Y; Wei X
EBioMedicine; 2019 Feb; 40():118-134. PubMed ID: 30711520
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
[TBL] [Abstract][Full Text] [Related]
12. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.
Fiani ML; Barreca V; Sargiacomo M; Ferrantelli F; Manfredi F; Federico M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878276
[TBL] [Abstract][Full Text] [Related]
13. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
14. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
15. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
17. Targeting tumor-associated macrophages in the tumor microenvironment.
Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
[TBL] [Abstract][Full Text] [Related]
18. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
Liu H; Yao M; Ren J
Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
[TBL] [Abstract][Full Text] [Related]
19. Functionally and Metabolically Divergent Melanoma-Associated Macrophages Originate from Common Bone-Marrow Precursors.
Pizzurro GA; Bridges K; Jiang X; Vidyarthi A; Miller-Jensen K; Colegio OR
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444440
[TBL] [Abstract][Full Text] [Related]
20. Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Scott EM; Jacobus EJ; Lyons B; Frost S; Freedman JD; Dyer A; Khalique H; Taverner WK; Carr A; Champion BR; Fisher KD; Seymour LW; Duffy MR
J Immunother Cancer; 2019 Nov; 7(1):320. PubMed ID: 31753017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
